Stocky turns companies like Sabra Health Care REIT, Inc. into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Hold. SBRA's 72/100 Growth Compounder Score reflects solid operational momentum, but a 29.3× forward P/E prices in execution risk. Leadership Alignment is modest (55/100)—no founder-CEO alignment or significant insider ownership signals conviction. Vulnerability is adequate but not a moat: the REIT's financial buffer absorbs near-term stress, yet rising rates remain structural headwind for dividend yields.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for Sabra Health Care REIT, Inc.:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 62/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates Sabra Health Care REIT, Inc. (SBRA) at 62/100 — a Hold — quality is solid but valuation or risk factors cap upside. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Hold. SBRA's 72/100 Growth Compounder Score reflects solid operational momentum, but a 29.3× forward P/E prices in execution risk. Leadership Alignment is modest (55/100)—no founder-CEO alignment or significant insider ownership signals
SBRA's current Stocky Verdict is 62/100, placing it in the "Hold" band. This composite combines a 72/100 Compounder score, 55/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for Sabra Health Care REIT, Inc. yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
Sabra Health Care REIT, Inc. scores 55/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
Sabra Health Care REIT, Inc.'s Vulnerability Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to Sabra Health Care REIT, Inc..
Sign up free and unlock the full analysis on SBRA — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for SBRA in the app.
